News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
‘Cancer prevention should not be an afterthought, it should be the first line of defense.’ – Phil Castle
Photo taken from Phil Castle/X
Jun 27, 2024, 13:16

‘Cancer prevention should not be an afterthought, it should be the first line of defense.’ – Phil Castle

NCI Division of Cancer Prevention shared on LinkedIn: 

“‘Cancer prevention should not be an afterthought, it should be the first line of defense.’

National Cancer Institute (NCI) Division of Cancer Prevention Director Phil Castle welcomes the Prevention Conference 2024 crowd in Boston today with partners Cancer Research UK (CRUK) and American Cancer Society.”
ACS American Cancer Society cancer Cancer Prevention Cancer Research UK CRUK National Cancer Institute NCI NCI Division of Cancer Prevention OncoDaily Oncology Phil Castle
Insight
Jun 28, 2024, 13:09
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Insight
Jun 28, 2024, 13:00
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Insight
Jun 28, 2024, 12:53
Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski
Insight
Jun 28, 2024, 12:50
AI model may yield better outcomes for prostate cancer - UCLA Health
Blog
Jun 28, 2024, 12:46
The partnership between UICC and Tradition Genève 1959 will enable access to early breast cancer detection services for women
Blog
Jun 28, 2024, 12:37
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Blog
Jun 28, 2024, 12:35
Over €14 M to Advance Development of Tacalyx's Cancer Therapeutics Targeting TACAs
Insight
Jun 28, 2024, 12:26
Dr. Madhu Shetti of Balmere On The 5 Things Everyone Needs To Know About Cancer
Insight
Jun 28, 2024, 12:15
Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling
Blog
Jun 28, 2024, 12:11
Carmen Uscatu: When do we know that we are on the right track?
Blog
Jun 28, 2024, 12:02
Herbert Loong: Regulatory Harmonisation For Oncology Clinical Trials in the APAC Region
Societies
Jun 28, 2024, 12:00
Prospective study on the prognostic impact of mutKRAS at ESMOGI24